Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             85 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Alteration in RGS2 expression level is associated with changes in haloperidol induced extrapyramidal features in a mutant mouse model Greenbaum, Lior
 2012
 22 Supplement 3 p. 379-386
8 p.
 artikel
2 Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: Results from the CO-MED trial Friedman, Edward S.
 2012
 22 Supplement 3 p. 183-199
17 p.
 artikel
3 C.10.01 Evolved thinking in mood disorders: new insights into disease pathophysiology Leonard, B.E.
 2012
 22 Supplement 3 p. S448-
1 p.
 artikel
4 Chronic treatment with lithium or valproate modulates the expression of Homer1b/c and its related genes Shank and Inositol 1,4,5-trisphosphate receptor de Bartolomeis, Andrea
 2012
 22 Supplement 3 p. 527-535
9 p.
 artikel
5 Clozapine resistance: Augmentation strategies Porcelli, Stefano
 2012
 22 Supplement 3 p. 165-182
18 p.
 artikel
6 C.08.01 The multidimensional perspective of Bipolar I disorder Gonzalez-Pinto, A.
 2012
 22 Supplement 3 p. S447-
1 p.
 artikel
7 C.03.01 Treatment options in schizophrenia Schmauss, M.
 2012
 22 Supplement 3 p. S443-
1 p.
 artikel
8 Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: Results from a 3-month prospective open-label study Wampers, Martien
 2012
 22 Supplement 3 p. 17-26
10 p.
 artikel
9 Does early improvement predict endpoint response in patients with generalized anxiety disorder (GAD) treated with pregabalin or venlafaxine XR? Baldwin, David S.
 2012
 22 Supplement 3 p. 137-142
6 p.
 artikel
10 ECNP Calendar of Events 2012
 22 Supplement 3 p. I-
1 p.
 artikel
11 ECNP Calendar of Events 2012
 22 Supplement 3 p. I-
1 p.
 artikel
12 Editorial Board 2012
 22 Supplement 3 p. IFC-
1 p.
 artikel
13 Efficacy of a targeted cognitive–behavioral treatment program for cannabis use disorders (CANDIS*) Hoch, E.
 2012
 22 Supplement 3 p. 267-280
14 p.
 artikel
14 E.02.02 How to predict and treat suicidal behaviour in schizophrenia Taylor, M.
 2012
 22 Supplement 3 p. S149-
1 p.
 artikel
15 Magnetic resonance imaging studies in unipolar depression: Systematic review and meta-regression analyses Arnone, D.
 2012
 22 Supplement 3 p. 1-16
16 p.
 artikel
16 Marked inbred mouse strain difference in the expression of quinpirole induced compulsive like behavior based on behavioral pattern analysis de Haas, Ria
 2012
 22 Supplement 3 p. 657-663
7 p.
 artikel
17 Onset, time course and trajectories of improvement with antidepressants Lam, Raymond W.
 2012
 22 Supplement 3 p. S492-S498
7 p.
 artikel
18 P.3.a.013 A post-hoc analysis of the negative symptom factor score in a proof-of-concept study of glycine reuptake inhibitor bitopertin in schizophrenia Umbricht, D.
 2012
 22 Supplement 3 p. S311-
1 p.
 artikel
19 P.6.a.001 Augmentation therapy of aripiprazole with escitalopram in patients with co-occurrence of depression and alcohol dependence Lee, Y.
 2012
 22 Supplement 3 p. S389-
1 p.
 artikel
20 P.7.a.006 Cognitive impairment and level of functioning in early-onset psychosis: 8 years follow-up study Remberk, B.
 2012
 22 Supplement 3 p. S417-
1 p.
 artikel
21 P.3.007 A common variant in human ErbB4 regulates GABA cerebrospinal fluid concentrations Vinkers, C.H.
 2012
 22 Supplement 3 p. S57-S58
2 p.
 artikel
22 P.2.a.012 Evidence that self-reported sleep impacts on momentary affect in daily life and predicts follow-up depressive symptomatology de Wild-Hartmann, J.A.
 2012
 22 Supplement 3 p. S230-S231
2 p.
 artikel
23 P.2.a.009 Low lipid levels are risk factors for suicidal behaviour in patients with depression Aini-yet, B.
 2012
 22 Supplement 3 p. S229-
1 p.
 artikel
24 P.3.004 Amphetamine-opioid interactions in the human brain reward system – a PET study using [11C]carfentanil Guterstam, J.
 2012
 22 Supplement 3 p. S55-
1 p.
 artikel
25 P.1.024 A role for SIRT6 in cocaine addiction Dikshtein, Y.
 2012
 22 Supplement 3 p. S24-S25
2 p.
 artikel
26 P.2.a.026 Significant clinical, cognitive and imaging findings of bilateral magnetic seizure therapy in 26 treatment-resistant depression patients Kayser, S.
 2012
 22 Supplement 3 p. S239-
1 p.
 artikel
27 P.1.a.006 The association of GRIA1 polymorphisms with schizophrenia in the Korean population Lee, S.M.
 2012
 22 Supplement 3 p. S156-
1 p.
 artikel
28 P.4.a.012 Treatment effect prediction of cognitive behavioural therapy in panic disorder patients – fMRI study Grambal, A.
 2012
 22 Supplement 3 p. S364-
1 p.
 artikel
29 P.1.a.009 Variation in the BDNF gene impacts on social stress-sensitivity: replication and extension of a gene–environment interaction finding van Winkel, M.
 2012
 22 Supplement 3 p. S158-
1 p.
 artikel
30 P.7.b.005 Decreased serum levels of brain derived neurotrophic factor in adults with ADHD Ramos-Quiroga, J.
 2012
 22 Supplement 3 p. S425-S426
2 p.
 artikel
31 P.2.b.011 Depression-like symptoms and neurodegeneration under zinc-deficient conditions Mlyniec, K.
 2012
 22 Supplement 3 p. S247-
1 p.
 artikel
32 P.2.b.015 Electrophysiological effects of the multimodal antidepressant Lu AA21004 on serotonin transmission in the rat hippocampus Lecours, M.
 2012
 22 Supplement 3 p. S249-
1 p.
 artikel
33 P.5.b.001 Levels of brain synaptic and axonal proteins in 5XFAD mouse model of Alzheimer's disease Sonn, K.
 2012
 22 Supplement 3 p. S383-
1 p.
 artikel
34 P.6.b.006 mGluR5 receptors on neurons expressing D1 dopamine receptors control escalation of alcohol drinking after abstinence Sikora, M.
 2012
 22 Supplement 3 p. S397-S398
2 p.
 artikel
35 P.3.c.018 A placebo-controlled study of efficacy/safety of aripiprazole intramuscular depot for long-term maintenance treatment of schizophrenia Sanchez, R.
 2012
 22 Supplement 3 p. S327-
1 p.
 artikel
36 P.3.c.032 Comparison of metabolic changes between patients with schizophrenia taking clozapine and the other antipsychotics Lee, N.Y.
 2012
 22 Supplement 3 p. S335-
1 p.
 artikel
37 P.1.c.015 Differential effects of acute and sub-chronic PCP in rodent cognition: reversal with a selective mGlu2 negative allosteric modulator RO4491533 Embrechts, S.
 2012
 22 Supplement 3 p. S175-
1 p.
 artikel
38 P.1.c.001 Effects of (S)-3,4-DCPG, a selective agonist of glutamate mGlu8 receptors, on sleep and wakefulness in the rat Scesa, G.L.
 2012
 22 Supplement 3 p. S166-S167
2 p.
 artikel
39 P.2.c.013 Efficacy and safety of selegiline transdermal system for atypical depression: pooled analysis of short-term placebo-controlled trials Patkar, A.A.
 2012
 22 Supplement 3 p. S257-S258
2 p.
 artikel
40 P.3.c.008 Glutamate levels in the associative striatum decrease with antipsychotic treatment in first-episode psychosis de la Fuente-Sandoval, C.
 2012
 22 Supplement 3 p. S321-
1 p.
 artikel
41 P.1.c.018 Impact of nitric oxide synthase inhibitors on rotational behaviour and dopamine metabolism in 6-OHDA-lesioned rats receiving L-DOPA Czarnecka, A.
 2012
 22 Supplement 3 p. S177-
1 p.
 artikel
42 P.3.c.005 Influence of cannabis abuse on selective neuropsychological tests in schizophrenia patients Krysta, K.
 2012
 22 Supplement 3 p. S319-
1 p.
 artikel
43 P.6.c.002 Naltrexone for opioid dependence: oral, implantable, and injectable Krupitsky, E.
 2012
 22 Supplement 3 p. S399-S400
2 p.
 artikel
44 P.7.c.002 Risk of diabetes in children and adolescents exposed to second generation antipsychotics – a nationwide case-control study Nielsen, R.E.
 2012
 22 Supplement 3 p. S427-
1 p.
 artikel
45 P.2.011 Decreased levels of allopregnanolone induced by oral contraceptives are associated with a reduction in social behaviour and sexual motivation in rats Berretti, R.
 2012
 22 Supplement 3 p. S40-S41
2 p.
 artikel
46 P.3.d.008 Glycogen synthase kinase (GSK)-3β signalling pathway in the rodent prefrontal cortex: a role in schizophrenia? Koros, E.
 2012
 22 Supplement 3 p. S348-S349
2 p.
 artikel
47 P.3.d.003 Increased pre-synaptic striatal uptake of dopamine as a potential mechanism of antipsychotic failure Amato, D.
 2012
 22 Supplement 3 p. S345-S346
2 p.
 artikel
48 P.1.d.003 Maternal intake of omega-3 improves long-term potentiation in the dentate gyrus and performance in the Morris water maze in rats Kavraal, S.
 2012
 22 Supplement 3 p. S183-
1 p.
 artikel
49 P.6.d.004 Methamphetamine cross-sensitises to stimulatory effects of modafinil on locomotor mouse behaviour Merhautová, J.
 2012
 22 Supplement 3 p. S407-
1 p.
 artikel
50 P.1.d.007 Selective NMDA-NR2B receptor antagonist with neurogenic properties, Ro 25-6981 facilitates repeated spatial learning in adult rats Solovieva, O.A.
 2012
 22 Supplement 3 p. S185-S186
2 p.
 artikel
51 P.2.d.011 Sex differences in antidepressant response following adrenalectomy and stable corticosterone replacement Kokras, N.
 2012
 22 Supplement 3 p. S273-S274
2 p.
 artikel
52 P.2.e.011 Irreversible lithium-induced neurotoxicity syndrome Sastre, J. de Santiago
 2012
 22 Supplement 3 p. S282-
1 p.
 artikel
53 P.1.e.008 Molecular connectivity in patients with unilateral temporal lobe epilepsy investigated with [18F]FDG PET Vanicek, T.
 2012
 22 Supplement 3 p. S196-
1 p.
 artikel
54 P.4.e.001 Screening for anxiety disorders in patients with coronary artery disease using self-rating scales Bunevicius, A.
 2012
 22 Supplement 3 p. S372-S373
2 p.
 artikel
55 P.3.e.007 Substance use and pharmaceutical choices for patients who are involuntarily hospitalised in the Psychiatric Hospital of Athens Tsopelas, C.
 2012
 22 Supplement 3 p. S353-S354
2 p.
 artikel
56 P.7.e.002 The effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD Biederman, J.
 2012
 22 Supplement 3 p. S436-
1 p.
 artikel
57 P.4.e.004 The frequency of anxiety disorders in parents of children with attention deficit hyperactivity disorder Karamustafalioglu, K.
 2012
 22 Supplement 3 p. S374-S375
2 p.
 artikel
58 P.2.e.014 The symptom structure of bipolar acute episodes: the search for the mixing link Ribas, M. Valentí
 2012
 22 Supplement 3 p. S283-S284
2 p.
 artikel
59 P.1.f.002 Autism spectrum disorders in adults affected by schizophrenia and obsessive compulsive disorders Magnano, F.
 2012
 22 Supplement 3 p. S205-
1 p.
 artikel
60 P.3.f.001 Effect of different antipsychotics on cytokines and tryptophan metabolites after different immune challenges in astrocytes culture Lopez, Y. Pujol
 2012
 22 Supplement 3 p. S355-S356
2 p.
 artikel
61 P.2.f.001 Effects of chronic lithium treatment on long-term potentiation and some behavioral tests in adult rats Süer, C.
 2012
 22 Supplement 3 p. S292-S293
2 p.
 artikel
62 P.4.001 Fronto-striato-cerebellar dysregulation in adolescents with depression during motivated attention Chantiluke, K.
 2012
 22 Supplement 3 p. S84-
1 p.
 artikel
63 P.1.g.014 Automated tests of attention and information processing as an alternative to the Paced Auditory Serial Addition Test (PASAT) in clinical trials in multiple sclerosis Wesnes, K.
 2012
 22 Supplement 3 p. S212-S213
2 p.
 artikel
64 P.4.015 Gene expression profile associated with major depression and with antidepressant response Cattaneo, A.
 2012
 22 Supplement 3 p. S95-S96
2 p.
 artikel
65 P.3.010 Genetic variability at IMPA-2, INPP-1 and glycogen synthase kinase (GSK)-3β increases the risk of suicidal behaviour in bipolar patients Jimenez, E.
 2012
 22 Supplement 3 p. S60-S61
2 p.
 artikel
66 P.1.g.011 No deleterious effect on mood and cognition after ten repetitive transcranial magnetic stimulation sessions: a double-blind sham study Moulier, V.
 2012
 22 Supplement 3 p. S210-S211
2 p.
 artikel
67 P.2.g.009 One year follow-up of repetitive TMS efficacy in treatment-resistant major depression: report of two cases Durmaz, O.
 2012
 22 Supplement 3 p. S300-S301
2 p.
 artikel
68 P.2.h.001 The effect of citalopram treatment on lipopolysaccharide-induced alterations in contextual learning and brain plasticity in the adult mouse hippocampus Jaako, K.
 2012
 22 Supplement 3 p. S302-S303
2 p.
 artikel
69 P.1.010 Immunoglobulin G as a potential biomarker for posttraumatic stress disorder (PTSD) Herrmann, L.
 2012
 22 Supplement 3 p. S11-S12
2 p.
 artikel
70 P.1.i.004 Neu-P11: a novel drug for the treatment of insomnia and central sensitivity syndrome symptoms – results of a Phase-Ib study Katz, A.
 2012
 22 Supplement 3 p. S220-S221
2 p.
 artikel
71 P.2.003 Inhibition of the phosphatidylinositol-3 kinase cascade in corticolimbic structures: possible target to erase fear memories Kritman, M.
 2012
 22 Supplement 3 p. S34-S35
2 p.
 artikel
72 P.4.004 P-glycoprotein inhibition enhances transport of the antidepressant imipramine across the blood-brain barrier O'Brien, F.E.
 2012
 22 Supplement 3 p. S86-S87
2 p.
 artikel
73 P.3.021 Potential benefits of slow titration of paroxetine treatment in elderly population: 6-month results from a naturalistic setting Gibiino, S.
 2012
 22 Supplement 3 p. S69-S70
2 p.
 artikel
74 P.1.007 Time-course analysis of hormonal and neuroplastic changes in rats exposed to prenatal stress Luoni, A.
 2012
 22 Supplement 3 p. S8-S9
2 p.
 artikel
75 Reduced plasma levels of asymmetric Di-Methylarginine (ADMA) in patients with alcohol dependence normalize during withdrawal Frieling, Helge
 2012
 22 Supplement 3 p. 836-840
5 p.
 artikel
76 S.04.08 Analysis of miRNome expression profiles in hippocampus of rats treated with antidepressants Pelizzari, M.
 2012
 22 Supplement 3 p. S118-
1 p.
 artikel
77 S.21.01 Deep brain stimulation for OCD and Tourette syndrome Cavanna, A.
 2012
 22 Supplement 3 p. S138-
1 p.
 artikel
78 S.05.03 Early intervention Utens, E.M.W.J.
 2012
 22 Supplement 3 p. S119-S120
2 p.
 artikel
79 S.07.04 Genetic variability at IMPA-2, INPP-1 and glycogen synthase kinase (GSK)-3β increases the risk of suicidal behaviour in bipolar patients Jimenez, E.
 2012
 22 Supplement 3 p. S122-
1 p.
 artikel
80 S.26.01 Impact of childhood ADHD symptoms on later depressive disorders Purper-Ouakil, D.
 2012
 22 Supplement 3 p. S143-S144
2 p.
 artikel
81 S.20.02 Neural correlates of cognitive flexibility in monkeys Snyder, L.H.
 2012
 22 Supplement 3 p. S137-
1 p.
 artikel
82 S.01.01 Neural mechanisms of pathological gambling: fMRI studies of the motivational and impulse control system Goudriaan, A.E.
 2012
 22 Supplement 3 p. S113-
1 p.
 artikel
83 S.09.01 The role of contextual factors in predicting cognitive improvement Huddy, V.
 2012
 22 Supplement 3 p. S125-
1 p.
 artikel
84 S.14.02 Update of neuroimaging in social anxiety disorder Brühl, A.B.
 2012
 22 Supplement 3 p. S131-S132
2 p.
 artikel
85 Triple monoamine inhibitor tesofensine decreases food intake, body weight, and striatal dopamine D2/D3 receptor availability in diet-induced obese rats van de Giessen, Elsmarieke
 2012
 22 Supplement 3 p. 290-299
10 p.
 artikel
                             85 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland